Airway Clearance Device Sales

Airway Clearance Device Sales Market Outlook

The global Airway Clearance Device market is projected to reach approximately USD 3.5 billion by 2035, growing at a Compound Annual Growth Rate (CAGR) of around 7.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of chronic respiratory diseases such as Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), and bronchiectasis, along with the growing awareness of the benefits of airway clearance therapies. Additionally, advancements in technology and the introduction of innovative devices tailored to improve patient outcomes are driving market expansion. A rise in the aging population, combined with an increase in healthcare expenditure and improvements in healthcare infrastructure, further enhances the demand for airway clearance devices. The push towards home healthcare settings during the COVID-19 pandemic has also significantly accelerated the adoption of these devices, paving the way for sustained market growth.

Growth Factor of the Market

The growth of the Airway Clearance Device market can be attributed to several critical factors that influence both demand and supply. Firstly, there has been a noticeable increase in global awareness regarding respiratory health, leading to early diagnosis and intervention for chronic respiratory diseases. This heightened awareness is crucial, particularly in developing regions where healthcare access has improved. Secondly, technological advancements in device design and functionality have made airway clearance therapies more effective and user-friendly, encouraging more patients and healthcare providers to adopt these solutions. Additionally, the rising incidence of respiratory disorders due to environmental factors, such as pollution and smoking, continues to bolster the need for effective airway clearance solutions. Furthermore, the increase in home healthcare services has expanded the patient base utilizing portable airway clearance devices, significantly contributing to market growth. Lastly, supportive government policies and initiatives aimed at improving respiratory healthcare continue to play a pivotal role in driving this market forward.

Key Highlights of the Market

• Significant growth projected due to the rising prevalence of chronic respiratory conditions.
• Technological advancements are leading to innovative product developments enhancing device effectiveness.
• Increased adoption of homecare settings is changing the landscape of device utilization.
• Government initiatives and funding to improve respiratory health are boosting market growth.
• The market is experiencing a shift towards portable and user-friendly devices as patient comfort is prioritized.

By Product Type

Positive Expiratory Pressure Devices:

Positive Expiratory Pressure (PEP) devices are a crucial segment of the airway clearance market, designed to aid patients in expelling mucus from the lungs. These devices work by creating a pressure resistance during expiration, thereby promoting airway opening and mucus clearance. The growing prevalence of respiratory diseases, particularly Cystic Fibrosis and COPD, has spurred the demand for PEP devices, making them a primary choice among clinicians for improving pulmonary function. The simplicity of use, coupled with cost-effectiveness, further enhances their attractiveness, especially in homecare settings where patients require ease of operation. With a robust supply chain and increasing availability through various distribution channels, PEP devices are expected to maintain a significant share of the market in the coming years.

Oscillatory Positive Expiratory Pressure Devices:

Oscillatory Positive Expiratory Pressure (OPEP) devices represent another vital category within the airway clearance device market. These devices combine PEP therapy with airway oscillation to improve mucus clearance by facilitating more effective coughing. The unique design of OPEP devices allows for a more comfortable patient experience, which contributes to higher compliance rates. As healthcare providers seek to optimize patient outcomes, OPEP devices have become increasingly popular, particularly among patients with chronic lung diseases. The rising focus on personalized medicine and tailored therapies is also expected to drive growth in this segment, as OPEP devices can be adjusted to meet individual patient needs, enhancing their efficacy and acceptance among users.

High-Frequency Chest Wall Oscillation Devices:

High-Frequency Chest Wall Oscillation (HFCWO) devices are specialized equipment designed to deliver high-frequency vibrations to the chest wall, promoting mucus clearance in patients. These devices are primarily used in hospital settings but are increasingly being adapted for home use, catering to chronic respiratory disease patients requiring daily therapy. The effectiveness of HFCWO devices in improving lung function and reducing hospital visits has led to their growing adoption among healthcare professionals. Additionally, as research continues to support the efficacy of HFCWO devices in various respiratory conditions, the market for these devices is expected to experience steady growth. As a result, manufacturers are investing in innovations to enhance comfort and portability, which may further increase their clinical uptake.

Intrapulmonary Percussive Ventilation Devices:

Intrapulmonary Percussive Ventilation (IPV) devices represent an advanced approach to airway clearance by delivering a series of high-frequency pulses directly into the lungs, helping to dislodge mucus buildup. IPV technology is gaining traction due to its effectiveness in managing severe respiratory conditions and its ability to complement other airway clearance methods. The segment is likely to witness substantial growth as healthcare providers increasingly recognize IPV's benefits in both inpatient and outpatient settings. Moreover, the advent of portable IPV devices is indicative of the market's shift towards homecare solutions, enabling greater patient autonomy and compliance. As more studies underline the potential of IPV in improving patient quality of life, it is anticipated that this product type will see significant advancements and increased market share in the coming years.

Mechanical Cough Assist Devices:

Mechanical Cough Assist Devices are an innovative solution for patients who have difficulty generating effective coughs due to neuromuscular disorders or severe respiratory conditions. These devices assist in creating a strong, artificial cough by delivering positive pressure followed by a rapid shift to negative pressure, effectively clearing airway secretions. The growing awareness of the importance of effective cough assistance in improving respiratory function is driving the demand for these devices, especially in hospital settings. Furthermore, as healthcare systems strive toward enhancing chronic disease management strategies, Mechanical Cough Assist Devices are becoming integral to comprehensive respiratory care plans. With ongoing advancements in technology and device usability, this segment is poised for robust growth, further expanding the availability of these life-enhancing devices to patients in need.

By Application

Cystic Fibrosis:

Cystic Fibrosis (CF) is one of the primary conditions driving the demand for airway clearance devices, given the significant mucus production associated with the disease. Patients with CF require regular airway clearance to maintain lung health and prevent infections. The effectiveness of various airway clearance devices in reducing hospital admissions and improving lung function in CF patients is well-documented. As healthcare providers focus on improving the quality of life and decreasing morbidity associated with CF, the market for airway clearance devices tailored for this application is expected to grow significantly. Increased research funding and support for CF care continue to enhance device usage, ensuring that patients have access to the latest technologies for optimal respiratory management.

Chronic Obstructive Pulmonary Disease:

The impact of Chronic Obstructive Pulmonary Disease (COPD) on public health is profound, and airway clearance devices play a key role in managing this condition. Patients with COPD often experience mucus retention, leading to exacerbations and hospitalizations. The effectiveness of airway clearance therapies in improving lung function and enhancing patient outcomes makes these devices invaluable in COPD management strategies. With the rising incidence of COPD globally, driven by factors such as smoking and environmental pollution, there is an increasing need for effective airway clearance solutions. Healthcare providers are likely to adopt these devices in routine care protocols, further propelling market growth for devices designed specifically for COPD patients.

Bronchiectasis:

Bronchiectasis, characterized by chronic inflammation and mucus accumulation in the lungs, represents a significant patient population that benefits from airway clearance devices. The availability of tailored therapies for this condition is critical, as proper mucus clearance is essential for preventing lung infections and maintaining respiratory function. The growing recognition of the importance of airway clearance in bronchiectasis management has led to increased utilization of devices such as PEP and OPEP devices. As awareness of bronchiectasis rises and diagnostic capabilities improve, the demand for effective airway clearance devices is expected to surge, making it a vital segment within the market.

Neuromuscular Disorders:

Patients with neuromuscular disorders often experience impaired respiratory muscle function, leading to ineffective cough and increased risk of pneumonia. Airway clearance devices, particularly mechanical cough assist devices, have become essential tools in managing these patients' respiratory health. Their ability to provide an effective cough mechanism not only helps in mucus clearance but also enhances overall lung capacity and oxygenation. As the population of patients with neuromuscular disorders continues to grow, the market for these devices tailored for this application is projected to expand significantly. Furthermore, ongoing research into novel therapies and technologies aiming to improve respiratory outcomes in these patients will likely drive further innovation within this sector.

Other Respiratory Conditions:

In addition to the primary applications mentioned, airway clearance devices are increasingly being utilized for other respiratory conditions, such as asthma and pneumonia, where mucus clearance is vital for recovery. The versatility of these devices allows healthcare providers to employ them across a range of respiratory issues, thereby broadening their market potential. As healthcare providers adopt a more holistic approach to respiratory care, the integration of airway clearance devices in treatment plans for various conditions is likely to grow. This expansion into other respiratory conditions reflects the ongoing commitment to improving patient outcomes and the potential for market growth in emerging therapeutic areas.

By Distribution Channel

Hospitals:

Hospitals remain a dominant distribution channel for airway clearance devices, primarily due to the critical nature of respiratory care provided in these settings. The utilization of various devices in emergency and inpatient care enables healthcare professionals to offer immediate and effective solutions for patients experiencing respiratory distress. The presence of trained staff and comprehensive treatment protocols in hospitals supports the adoption of advanced airway clearance technologies, making them a primary point of access for patients. Moreover, with the increasing burden of respiratory diseases leading to higher hospitalization rates, manufacturers are focusing on ensuring that their products are readily available in hospital environments to meet growing demand.

Homecare Settings:

The shift toward homecare settings has significantly influenced the distribution of airway clearance devices as more patients seek effective solutions for managing chronic respiratory conditions at home. The convenience of using these devices in the comfort of one’s home, coupled with advancements in portability and ease of use, has driven their adoption in this channel. Patients prefer devices that can seamlessly integrate into their daily routines while offering effective treatment options. The trend toward home healthcare has accelerated in recent years, particularly during the COVID-19 pandemic, as patients and providers recognize the value of at-home therapies. This segment is expected to continue growing as technology advances and the aging population increasingly requires at-home respiratory management solutions.

Specialty Clinics:

Specialty clinics play a crucial role in the distribution of airway clearance devices, particularly as they cater to specific patient populations with chronic respiratory diseases. These clinics often focus on comprehensive management of conditions such as Cystic Fibrosis, COPD, and bronchiectasis, providing tailored therapies that include the use of airway clearance devices. The specialized knowledge of healthcare providers in these settings ensures that patients receive appropriate guidance on device selection and usage, enhancing treatment adherence and outcomes. As specialty clinics expand and improve access to respiratory care, the demand for airway clearance devices is expected to increase accordingly, making this a vital channel in the market.

Online Retailers:

Online retail has emerged as a significant distribution channel for airway clearance devices, driven by the convenience of shopping and the growing trend toward e-commerce. Patients and caregivers increasingly prefer the option to purchase medical devices online, benefiting from a wider selection and potentially lower prices. Online platforms provide invaluable resources for patients to research product options, read reviews, and compare features before making a purchase. This accessibility is particularly essential for those in remote areas or with mobility challenges, making it easier for them to obtain necessary equipment. The rise of telehealth services further complements this trend as healthcare providers can prescribe devices, which patients can conveniently order online, leading to a more integrated approach to respiratory care.

Others:

Other distribution channels, including pharmacies and medical supply stores, also contribute to the availability of airway clearance devices. These locations often serve as accessible points for patients seeking immediate solutions for respiratory management. While the volume of sales through these channels may be lower than in hospitals and specialty clinics, they provide crucial support for patients in need of immediate access to airway clearance devices. Additionally, the presence of medical representatives in these settings can facilitate education and awareness about the importance and benefits of these devices, potentially driving further adoption. As the market evolves, manufacturers may explore partnerships with various distribution networks to ensure optimal reach and accessibility for patients across different demographics.

By Region

North America holds a significant share of the airway clearance device market, driven by advanced healthcare systems, high prevalence rates of chronic respiratory diseases, and a strong emphasis on innovative medical technologies. The region is expected to witness steady growth, with a CAGR of approximately 7.2% during the forecast period. Factors such as increased healthcare expenditure, favorable reimbursement policies, and rising awareness of respiratory health among the population continue to fuel demand for airway clearance devices in North America. Additionally, the presence of major market players in the region contributes to constant advancements in product offerings, further solidifying its position as a leader in the global market.

Europe is another key region in the airway clearance device market, characterized by a growing emphasis on respiratory health and patient-centered care. The region is experiencing increased investments in healthcare infrastructure, leading to enhanced access to airway clearance therapies. In Europe, the rising prevalence of respiratory diseases, coupled with the aging population, has led to greater acceptance and adoption of these devices. The market is anticipated to grow steadily, supported by advancements in technology and the increasing integration of digital health solutions. With ongoing research initiatives focused on improving respiratory care, Europe is poised for significant growth in the airway clearance device market.

Opportunities

One of the most significant opportunities in the airway clearance device market arises from the growing trend of telehealth and remote patient monitoring. As healthcare providers increasingly adopt digital health technologies to enhance patient care, the integration of airway clearance devices into these platforms presents a unique opportunity for manufacturers. By offering devices equipped with smart technology that allows for monitoring and data collection, companies can provide healthcare professionals with valuable insights into patient progress and compliance. This approach not only enhances patient engagement but also allows for timely interventions, leading to improved health outcomes. The rise of telehealth can serve as a catalyst for market growth, creating demand for innovative, connected airway clearance devices that cater to modern healthcare needs.

Another promising opportunity lies in the expansion of airway clearance devices into emerging markets where respiratory diseases are on the rise. Growing urbanization, shifts in lifestyle, and increasing pollution levels have led to a surge in chronic respiratory conditions in regions such as Asia Pacific and Latin America. By focusing on emerging economies, manufacturers can tap into a previously underserved patient population, addressing the critical need for effective respiratory therapies. Additionally, strategic partnerships with local healthcare providers and governments to improve infrastructure and access to care can further bolster market penetration. This expansion into emerging markets not only presents a lucrative opportunity for growth but also contributes to global health improvements by providing essential devices to those in need.

Threats

Despite the promising outlook for the airway clearance device market, several threats could hinder its growth trajectory. One of the primary concerns is the stringent regulatory environment surrounding medical devices, which can delay product approvals and increase compliance costs for manufacturers. The lengthy regulatory processes required for new devices, coupled with the need for extensive clinical trials, can create barriers to entry for smaller companies and stifle innovation. Additionally, the emergence of alternative therapies and technologies may also pose a threat to traditional airway clearance devices. As the medical community explores new methods for managing respiratory conditions, there is a risk that existing devices may become less relevant, potentially impacting market share and profitability.

Another significant threat to the airway clearance device market is the risk of market saturation, particularly in developed regions where many patients already have access to these devices. As competition intensifies and product offerings become increasingly similar, differentiating factors such as price, effectiveness, and usability may become less pronounced. This situation can lead to price wars, reducing profit margins for manufacturers and impacting their ability to invest in research and development for new, innovative products. Furthermore, if manufacturers fail to keep pace with technological advancements and changing patient preferences, they risk losing market share to more agile competitors. To navigate these challenges, it is essential for companies to focus on innovation, customer engagement, and robust marketing strategies to maintain a competitive edge in the market.

Competitor Outlook

• Medtronic
• Philips Respironics
• Hill-Rom Holdings, Inc.
• Smiths Medical
• AstraZeneca
• Vyaire Medical
• PARI Respiratory Equipment
• Allied Healthcare Products, Inc.
• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Respironics, Inc.
• Inspira Technologies Oxy B.H.N. Ltd.
• Hollister Incorporated
• ResMed
• CareFusion Corporation

The competitive landscape of the airway clearance device market is characterized by numerous large and small players striving to capture market share through innovation and strategic partnerships. Major companies like Medtronic and Philips Respironics dominate the market with a wide range of established products, advanced technologies, and extensive distribution networks. These companies leverage their resources to invest in research and development, ensuring that they remain at the forefront of technological advancements. Furthermore, the focus on expanding product lines to address diverse patient needs continues to strengthen their market positions. The competitive dynamics are influenced by the need for companies to differentiate themselves through effective marketing strategies, customer engagement, and ongoing product enhancements to maintain a competitive edge in this rapidly evolving market.

In addition to the established players, several emerging companies are making their mark in the airway clearance device market. Companies such as Vyaire Medical and PARI Respiratory Equipment are gaining traction by focusing on niche markets and innovative products specifically designed for targeted respiratory conditions. Their ability to quickly adapt to changing market demands and develop user-friendly devices positions them favorably for growth. The increasing focus on patient-centric solutions and the integration of digital health technologies also provide these emerging companies with opportunities to differentiate themselves from larger competitors. As the market continues to evolve, these smaller players are likely to play an important role in driving innovation and competition within the industry.

The emphasis on strategic collaborations and partnerships is becoming increasingly important in the competitive landscape of the airway clearance device market. Major players are actively seeking alliances with healthcare providers, research institutions, and technology companies to enhance their product offerings and expand their reach. For instance, collaborations aimed at developing integrated solutions that combine airway clearance devices with telehealth platforms allow companies to offer comprehensive respiratory care solutions. These partnerships not only facilitate enhanced patient outcomes but also provide companies with insights into emerging trends and patient needs. As the market continues to grow and evolve, this collaborative approach will be essential for companies to stay competitive and meet the demands of an increasingly sophisticated healthcare environment.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 ResMed
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 AstraZeneca
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smiths Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Vyaire Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Respironics, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Philips Respironics
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 CareFusion Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Hollister Incorporated
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Hill-Rom Holdings, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Thermo Fisher Scientific
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 PARI Respiratory Equipment
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Allied Healthcare Products, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Inspira Technologies Oxy B.H.N. Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Airway Clearance Device Sales Market, By Application
    • 6.1.1 Cystic Fibrosis
    • 6.1.2 Chronic Obstructive Pulmonary Disease
    • 6.1.3 Bronchiectasis
    • 6.1.4 Neuromuscular Disorders
    • 6.1.5 Other Respiratory Conditions
  • 6.2 Airway Clearance Device Sales Market, By Product Type
    • 6.2.1 Positive Expiratory Pressure Devices
    • 6.2.2 Oscillatory Positive Expiratory Pressure Devices
    • 6.2.3 High-Frequency Chest Wall Oscillation Devices
    • 6.2.4 Intrapulmonary Percussive Ventilation Devices
    • 6.2.5 Mechanical Cough Assist Devices
  • 6.3 Airway Clearance Device Sales Market, By Distribution Channel
    • 6.3.1 Hospitals
    • 6.3.2 Homecare Settings
    • 6.3.3 Specialty Clinics
    • 6.3.4 Online Retailers
    • 6.3.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Airway Clearance Device Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Airway Clearance Device Sales market is categorized based on

By Product Type

• Positive Expiratory Pressure Devices
• Oscillatory Positive Expiratory Pressure Devices
• High-Frequency Chest Wall Oscillation Devices
• Intrapulmonary Percussive Ventilation Devices
• Mechanical Cough Assist Devices

By Application

• Cystic Fibrosis
• Chronic Obstructive Pulmonary Disease
• Bronchiectasis
• Neuromuscular Disorders
• Other Respiratory Conditions

By Distribution Channel

• Hospitals
• Homecare Settings
• Specialty Clinics
• Online Retailers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Philips Respironics
• Hill-Rom Holdings, Inc.
• Smiths Medical
• AstraZeneca
• Vyaire Medical
• PARI Respiratory Equipment
• Allied Healthcare Products, Inc.
• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Respironics, Inc.
• Inspira Technologies Oxy B.H.N. Ltd.
• Hollister Incorporated
• ResMed
• CareFusion Corporation